REGULATION OF MMTV IN T-CELL TUMORS
REGULATION OF MMTV IN T-CELL TUMORS
批准号:
3172591
负责人:
Jaquelin Page Dudley
金额:
$18.69万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-07-01 至 1994-03-31
关键词:
Baculoviridae T lymphocyte antibody formation binding proteins carcinoma clone cells gene deletion mutation gene expression gene mutation genetic enhancer element genetic manipulation genetic mapping genetic transcription genetically modified animals glucocorticoids intracellular transport laboratory mouse mammary gland molecular oncology monoclonal antibody mouse leukemia mouse mammary tumor virus northern blottings nucleic acid probes nucleic acid sequence nucleoproteins oncogenes oncogenic virus open reading frames orotate phosphoribosyltransferase posttranscriptional RNA processing posttranslational modifications protein purification provirus ribonucleoproteins transfection viral leukemogenesis virus RNA virus envelope virus genetics virus protein virus replication
中文摘要
小鼠乳腺肿瘤病毒(MMTV)是一种B型逆转录病毒,
主要是小鼠的乳腺癌。 MMTV长末端重复序列(LTR)
有一个不寻常的1200 bp的U3区,含有转录调节基因,
该病毒的信号以及长的开放阅读框(ORF)潜在地
编码36 kD蛋白。 该ORF在所有已知的MMTV中是保守的
菌株和观察到的碱基取代给出了很大程度上保守的或
沉默氨基酸的变化;这表明蛋白质功能的保守性。
此外,具有适当的
已在乳腺和肿瘤中鉴定了orf mRNA的结构
来自高乳腺癌小鼠品系。 尽管据报道orf
是一种病毒反式激活因子,这一点尚未得到证实,
尚未确认身份。 最近我们过度表达了未融合的
来自昆虫细胞中的重组杆状病毒的MMTV orf产物。 因为
我们推测,36 kD的ORF产物似乎是一种核蛋白
ORF是转录正或负调节子,
间接或协同参与MMTV诱导的肿瘤。 几
我们将使用各种方法来检验这一假设。 在基因方面,我们
将构建不能合成ORF的MMTV前病毒,
分析其在培养中的复制潜力。 转基因小鼠
将评估过表达ORF产物的组织特异性
ORF的表达、内源性MMTV RNA水平以及
自发性肿瘤 在另一种方法中,我们将使用杆状病毒-
生产ORF蛋白,以开发所需的多克隆抗体,
哺乳动物细胞中ORF产物的鉴定和表征
表达整合的MMTV前病毒。 杆状病毒产生的蛋白质
也将用于生化分析。 细胞内的位置和
将在昆虫细胞中检测ORF的翻译后修饰,
并且部分纯化的ORF将用于评估核酸
蛋白质的结合特性。 最后,杆状病毒ORF蛋白
将用于体外转录反应以确定ORF是否
对MMTV转录有正或负的影响。 因为
MMTV ORF的不寻常性质和病毒的一般保守性,
因此,ORF可能在MMTV中起着独特的作用。
复制或肿瘤发生。
英文摘要
The mouse mammary tumor virus (MMTV) is a B type retrovirus which causes
primarily mammary carcinomas in mice. The MMTV long terminal repeat (LTR)
has an unusual 1200 bp U3 region containing the transcription regulatory
signals of the virus as well as a long open reading frame (orf) potentially
encoding a protein of 36 kD. This orf is conserved in all known MMTV
strains and the observed base substitutions give largely conservative or
silent amino acid changes; this suggests conservation of protein function.
In addition, a 1.7 kb spliced transcript which has the appropriate
structure for orf mRNA has been identified in mammary glands and tumors
from high mammary cancer mouse strains. Although orf has been reported to
be a viral transactivator, this has not been confirmed, and the orf product
has not been identified. Very recently we have overexpressed the unfused
MMTV orf product from a recombinant baculovirus in insect cells. Because
the 36 kD orf product appears to be a nuclear protein, we have speculated
that orf is a positive or negative regulator of transcription which
participates indirectly or cooperatively in MMTV-induced tumors. Several
approaches will be used to test this hypothesis. In a genetic approach, we
will construct an MMTV provirus which is incapable of orf synthesis for
analysis of its replication potential in culture. Transgenic mice
overexpressing the orf product will be assessed for the tissue-specific
expression of orf, level of endogenous MMTV RNA, and the incidence of
spontaneous tumors. In another approach, we will use the baculovirus-
produced orf protein to develop polyclonal antibodies needed for
identification and characterization of the orf product in mammalian cells
expressing integrated MMTV proviruses. The baculovirus-produced protein
also will be used for biochemical analysis. The intracellular location and
posttranslational modifications of orf will be examined in insect cells,
and partially purified orf will be used to evaluate the nucleic acid
binding properties of the protein. Finally, the baculovirus orf protein
will be employed in in vitro transcription reactions to determine if orf
has either positive or negative effects on MMTV transcription. Because of
the unusual nature of the MMTV orf and the general conservation of viral
genetic information, it is likely that orf plays a unique role in MMTV
replication or tumorigenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Apobecs in Retroviral Immunity
-
批准号:10220683
-
项目类别:
-
资助金额:$45.28万
-
财政年份:2017
-
负责人:Jaquelin Page Dudley
-
依托单位:
Role of Apobecs in Retroviral Immunity
-
批准号:9756136
-
项目类别:
-
资助金额:$45.28万
-
财政年份:2017
-
负责人:Jaquelin Page Dudley
-
依托单位:
Endogenous Retroviruses and the Immune Response to Pathogens
-
批准号:8652435
-
项目类别:
-
资助金额:$18.77万
-
财政年份:2013
-
负责人:Jaquelin Page Dudley
-
依托单位:
Endogenous Retroviruses and the Immune Response to Pathogens
-
批准号:8492239
-
项目类别:
-
资助金额:$22.61万
-
财政年份:2013
-
负责人:Jaquelin Page Dudley
-
依托单位:
Retroviral Subversion of ERAD and Intrinsic Immunity
-
批准号:8542800
-
项目类别:
-
资助金额:$34.33万
-
财政年份:2012
-
负责人:Jaquelin Page Dudley
-
依托单位:
Retroviral Subversion of ERAD and Intrinsic Immunity
-
批准号:8687620
-
项目类别:
-
资助金额:$35.45万
-
财政年份:2012
-
负责人:Jaquelin Page Dudley
-
依托单位:
Retroviral Subversion of ERAD and Intrinsic Immunity
-
批准号:8438721
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2012
-
负责人:Jaquelin Page Dudley
-
依托单位:
Post-Transcriptional Regulation of MMTV
-
批准号:7568745
-
项目类别:
-
资助金额:$25.68万
-
财政年份:2006
-
负责人:Jaquelin Page Dudley
-
依托单位:
Post-Transcriptional Regulation of MMTV
-
批准号:7215596
-
项目类别:
-
资助金额:$25.68万
-
财政年份:2006
-
负责人:Jaquelin Page Dudley
-
依托单位:
Post-Transcriptional Regulation of MMTV
-
批准号:7777297
-
项目类别:
-
资助金额:$25.68万
-
财政年份:2006
-
负责人:Jaquelin Page Dudley
-
依托单位:
Post-Transcriptional Regulation of MMTV
-
批准号:7356436
-
项目类别:
-
资助金额:$25.68万
-
财政年份:2006
-
负责人:Jaquelin Page Dudley
-
依托单位:
Post-Transcriptional Regulation of MMTV
-
批准号:7094971
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2006
-
负责人:Jaquelin Page Dudley
-
依托单位:
MOUSE MAMMARY TUMOR VIRUS AND DETERMINANTS OF LEUKEMOGENICITY
-
批准号:6580352
-
项目类别:
-
资助金额:$10.37万
-
财政年份:2002
-
负责人:Jaquelin Page Dudley
-
依托单位:
MOUSE MAMMARY TUMOR VIRUS AND DETERMINANTS OF LEUKEMOGENICITY
-
批准号:6448496
-
项目类别:
-
资助金额:$10.37万
-
财政年份:2001
-
负责人:Jaquelin Page Dudley
-
依托单位:
MOUSE MAMMARY TUMOR VIRUS AND DETERMINANTS OF LEUKEMOGENICITY
-
批准号:6315895
-
项目类别:
-
资助金额:$10.37万
-
财政年份:2000
-
负责人:Jaquelin Page Dudley
-
依托单位:
SUPERANTIGEN FUNCTION IN MMTV INFECTION
-
批准号:2094877
-
项目类别:
-
资助金额:$32.62万
-
财政年份:1993
-
负责人:Jaquelin Page Dudley
-
依托单位:
SUPERANTIGEN FUNCTION IN MMTV INFECTION
-
批准号:2094878
-
项目类别:
-
资助金额:$33.96万
-
财政年份:1993
-
负责人:Jaquelin Page Dudley
-
依托单位:
SUPERANTIGEN FUNCTION IN MMTV INFECTION
-
批准号:2094876
-
项目类别:
-
资助金额:$32.51万
-
财政年份:1993
-
负责人:Jaquelin Page Dudley
-
依托单位:
SUPERANTIGEN FUNCTION IN MMTV INFECTION
-
批准号:2429731
-
项目类别:
-
资助金额:$35.48万
-
财政年份:1993
-
负责人:Jaquelin Page Dudley
-
依托单位:
SUPERANTIGEN FUNCTION IN MMTV INFECTION
-
批准号:3197455
-
项目类别:
-
资助金额:$25.98万
-
财政年份:1993
-
负责人:Jaquelin Page Dudley
-
依托单位:
海外基金